Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.

Gupta T, Maitre M, Sastri GJ, Krishnatry R, Shirsat N, Epari S, Sahay A, Chinnaswamy G, Patil V, Shetty P, Moiyadi A.

J Neurooncol. 2019 Sep;144(2):283-291. doi: 10.1007/s11060-019-03225-9. Epub 2019 Jun 24.

PMID:
31236820
2.

Pediatric Patients With SHH Medulloblastoma Fail Differently as Compared With Adults: Possible Implications for Treatment Modifications.

Dasgupta A, Gupta T, Sridhar E, Shirsat N, Krishnatry R, Goda JS, Chinnaswamy G, Jalali R.

J Pediatr Hematol Oncol. 2019 Apr 9. doi: 10.1097/MPH.0000000000001484. [Epub ahead of print]

PMID:
30973484
3.

Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas.

Bharambe HS, Paul R, Panwalkar P, Jalali R, Sridhar E, Gupta T, Moiyadi A, Shetty P, Kazi S, Deogharkar A, Masurkar S, Yogi K, Kunder R, Gadewal N, Goel A, Goel N, Chinnaswamy G, Ramaswamy V, Shirsat NV.

Acta Neuropathol Commun. 2019 Apr 3;7(1):52. doi: 10.1186/s40478-019-0697-3.

4.

Patient and Caregiver Perspectives on How to Introduce Community-Based Palliative Care.

Rahman A, Fields T, Shirsat N, Suastegui-Olivares D, Enguidanos S.

J Palliat Med. 2018 Nov;21(11):1544-1545. doi: 10.1089/jpm.2018.0297. No abstract available.

PMID:
30383509
5.

Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.

Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Sastri GJ, Jalali R.

Neuro Oncol. 2019 Jan 1;21(1):115-124. doi: 10.1093/neuonc/noy093.

PMID:
29846693
6.

Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition.

Singh SV, Dakhole AN, Deogharkar A, Kazi S, Kshirsagar R, Goel A, Moiyadi A, Jalali R, Sridhar E, Gupta T, Shetty P, Gadewal N, Shirsat NV.

Biochem Biophys Res Commun. 2017 Sep 30;491(4):946-952. doi: 10.1016/j.bbrc.2017.07.140. Epub 2017 Jul 27.

PMID:
28757413
7.

Extraneuraxial metastases in medulloblastoma: is histology and molecular biology important?

Gupta T, Dasgupta A, Epari S, Shirsat N, Chinnaswamy G, Jalali R.

J Neurooncol. 2017 Nov;135(2):419-421. doi: 10.1007/s11060-017-2586-6. Epub 2017 Jul 28. No abstract available.

PMID:
28755322
8.

Indian Society of Neuro-Oncology consensus guidelines for the contemporary management of medulloblastoma.

Gupta T, Sarkar C, Rajshekhar V, Chatterjee S, Shirsat N, Muzumdar D, Pungavkar S, Chinnaswamy G, Jalali R.

Neurol India. 2017 Mar-Apr;65(2):315-332. doi: 10.4103/0028-3886.201841.

9.

ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.

Padul V, Epari S, Moiyadi A, Shetty P, Shirsat NV.

Genes Chromosomes Cancer. 2015 Dec;54(12):725-33. doi: 10.1002/gcc.22283. Epub 2015 Sep 10.

PMID:
26357005
10.

Verhulst and stochastic models for comparing mechanisms of MAb productivity in six CHO cell lines.

Shirsat N, Avesh M, English NJ, Glennon B, Al-Rubeai M.

Cytotechnology. 2016 Aug;68(4):1499-511. doi: 10.1007/s10616-015-9910-9. Epub 2015 Aug 26.

11.

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.

Gupta T, Shirsat N, Jalali R.

Curr Pediatr Rev. 2015;11(2):106-19. Review.

PMID:
26133181
12.

Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition.

Harmalkar M, Upraity S, Kazi S, Shirsat NV.

J Mol Neurosci. 2015 Oct;57(2):197-202. doi: 10.1007/s12031-015-0602-x. Epub 2015 Jun 25.

PMID:
26109525
13.

MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1.

Yogi K, Sridhar E, Goel N, Jalali R, Goel A, Moiyadi A, Thorat R, Panwalkar P, Khire A, Dasgupta A, Shetty P, Shirsat NV.

Oncoscience. 2015 Mar 2;2(4):334-48. eCollection 2015.

14.

MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.

Panwalkar P, Moiyadi A, Goel A, Shetty P, Goel N, Sridhar E, Shirsat N.

J Mol Neurosci. 2015 Jul;56(3):673-80. doi: 10.1007/s12031-015-0548-z. Epub 2015 Apr 10.

PMID:
25859932
15.

Revisiting Verhulst and Monod models: analysis of batch and fed-batch cultures.

Shirsat N, Mohd A, Whelan J, English NJ, Glennon B, Al-Rubeai M.

Cytotechnology. 2015 May;67(3):515-30. doi: 10.1007/s10616-014-9712-5. Epub 2014 Apr 5.

16.

MiR-224 expression increases radiation sensitivity of glioblastoma cells.

Upraity S, Kazi S, Padul V, Shirsat NV.

Biochem Biophys Res Commun. 2014 May 30;448(2):225-30. doi: 10.1016/j.bbrc.2014.04.095. Epub 2014 Apr 29.

PMID:
24785373
17.

Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas.

Kunder R, Jalali R, Sridhar E, Moiyadi A, Goel N, Goel A, Gupta T, Krishnatry R, Kannan S, Kurkure P, Deopujari C, Shetty P, Biyani N, Korshunov A, Pfister SM, Northcott PA, Shirsat NV.

Neuro Oncol. 2013 Dec;15(12):1644-51. doi: 10.1093/neuonc/not123. Epub 2013 Nov 7.

18.

Application of statistical techniques for elucidating flow cytometric data of batch and fed-batch cultures.

Shirsat N, Avesh M, English NJ, Glennon B, Al-Rubeai M.

Biotechnol Appl Biochem. 2013 Sep-Oct;60(5):536-45. doi: 10.1002/bab.1138. Epub 2013 Oct 10.

PMID:
23826910
19.

Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines.

Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN, Vaidya MM.

PLoS One. 2013;8(1):e53532. doi: 10.1371/journal.pone.0053532. Epub 2013 Jan 15.

20.

Process model comparison and transferability across bioreactor scales and modes of operation for a mammalian cell bioprocess.

Craven S, Shirsat N, Whelan J, Glennon B.

Biotechnol Prog. 2013 Jan-Feb;29(1):186-96. doi: 10.1002/btpr.1664. Epub 2012 Dec 20.

PMID:
23143896
21.

Myoepithelial expression of Fas and strong nuclear expression of FasL in epithelial cells: a marker for risk stratification of breast cancer.

Ranade KJ, Nerurkar AV, Phulpagar MD, Shirsat NV.

Indian J Cancer. 2012 Jan-Mar;49(1):60-5. doi: 10.4103/0019-509X.98921.

22.

Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway.

Gokhale A, Kunder R, Goel A, Sarin R, Moiyadi A, Shenoy A, Mamidipally C, Noronha S, Kannan S, Shirsat NV.

J Cancer Res Ther. 2010 Oct-Dec;6(4):521-9. doi: 10.4103/0973-1482.77072.

23.

Expression of survivin and p53 proteins and their correlation with hormone receptor status in Indian breast cancer patients.

Ranade KJ, Nerurkar AV, Phulpagar MD, Shirsat NV.

Indian J Med Sci. 2009 Nov;63(11):481-90. doi: 10.4103/0019-5359.58877.

PMID:
20075549
24.

Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers.

Jane C, Nerurkar AV, Shirsat NV, Deshpande RB, Amrapurkar AD, Karjodkar FR.

J Oral Pathol Med. 2006 Nov;35(10):595-601.

PMID:
17032391
25.
26.

Induction of BAALC and down regulation of RAMP3 in astrocytes treated with differentiation inducers.

Moodbidri MS, Shirsat NV.

Cell Biol Int. 2006 Mar;30(3):210-3. Epub 2005 Dec 22.

PMID:
16376586
27.

Antiproliferative activities of iron and platinum conjugates of salicylaldehyde semi-/thiosemicarbazones against C6 glioma cells.

Patole J, Padhye S, Moodbidri MS, Shirsat N.

Eur J Med Chem. 2005 Oct;40(10):1052-5.

PMID:
15913848
29.

Ohmic processing: Electrical conductivities of pork cuts.

Shirsat N, Lyng JG, Brunton NP, McKenna B.

Meat Sci. 2004 Jul;67(3):507-14. doi: 10.1016/j.meatsci.2003.12.003.

PMID:
22061526
31.

Growth inhibition and differentiation of C6 glioma cells on treatment with hmba.

Shirsat NV, Kayal JJ, Shaikh S, Mehta A.

Cell Biol Int. 2001;25(7):621-7.

PMID:
11448101
32.
33.

Olfaction in invertebrates.

Shirsat N, Siddiqi O.

Curr Opin Neurobiol. 1993 Aug;3(4):553-7. Review.

PMID:
8219721
35.
36.

A member of the ras gene superfamily is expressed specifically in T, B and myeloid hemopoietic cells.

Shirsat NV, Pignolo RJ, Kreider BL, Rovera G.

Oncogene. 1990 May;5(5):769-72.

PMID:
2189110
37.

Nucleotide sequence of cDNA for murine myeloperoxidase.

Venturelli D, Shirsat N, Gemperlein I, Bittenbender S, Hudson S, Rovera G.

Nucleic Acids Res. 1989 Jul 25;17(14):5852. No abstract available.

38.

The receptor for IgG on human normal and chronic myeloid leukemic granulocytes: functional and biochemical characterization.

Shirsat NV, Zingde SM, Advani SH, Gothoskar BP.

Cancer Biochem Biophys. 1989 May;10(3):235-45.

PMID:
2528404
39.

Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).

Mavilio F, Kreider BL, Valtieri M, Naso G, Shirsat N, Venturelli D, Reddy EP, Rovera G.

Oncogene. 1989 Mar;4(3):301-8.

PMID:
2468124
40.

Alteration of the program of terminal differentiation caused by oncogenes in the hemopoietic progenitor cell line 32D C13 (G).

Rovera G, Kreider B, Shirsat N, Venturelli D, Naso G, Mavilio F.

Ann N Y Acad Sci. 1989;567:154-64. Review. No abstract available.

PMID:
2552889
42.

Peptide mapping of proteins in gel bands after partial cleavage with acidic cyanogen bromide vapors.

Zingde SM, Shirsat NV, Gothoskar BP.

Anal Biochem. 1986 May 15;155(1):10-3.

PMID:
3717544

Supplemental Content

Loading ...
Support Center